Brief report on product development of Chinese Pharmaceutical Enterprises

Since the reform and opening up, China's biomedical industry has achieved rapid development Up to now, there are 7144 pharmaceutical companies in China published by CFDA, and their related products can be divided into the following categories: chemical drugs (H), Chinese patent medicine (z), biological products (s), in vitro diagnostic reagents (T), Chinese herbal pieces (y), medical gases (Q), pharmaceutical excipients (f), hollow capsules (J), special drugs (c), other (such as Chinese herbal formula particles) (x); or according to drug properties, they can be divided into: API (a), preparation (b), extract (E) with national standard According to their own R & D and capital strength, each enterprise has its own product line with its own characteristics These enterprises can be classified and counted according to the following classification methods According to the classification of product types, it can be divided into: 3822 chemical drugs (H), 2891 Chinese patent drugs (z), 219 biological products (s), 58 in vitro diagnostic reagents (T), 1299 pieces of Chinese herbal medicine (y), 692 medical gases (q), 453 pharmaceutical excipients (f), 119 hollow capsules (J), 228 special drugs (c), 41 other (e.g granules of traditional Chinese medicine formula) (x) The following is the statistical chart made according to the relevant classification principles The distribution of each province is roughly as follows: according to the classification of drug properties, there are 1858 manufacturers of APIs, 4011 manufacturers of preparations, and 87 manufacturers of extracts according to national standards The development of different types of drugs in various provinces of China is roughly ranked as follows: the top provinces of chemical drug production enterprises are Jiangsu Province, Guangdong Province and Zhejiang Province, among which Jiangsu Province has the largest number of chemical drug production enterprises, as many as 354, far ahead of other regions Jilin Province, Guangdong Province and Sichuan Province are the top provinces in the distribution of Chinese patent medicine manufacturing enterprises, among which Jilin Province has the largest number of Chinese patent medicine manufacturing enterprises, with as many as 210 The production enterprises of biological products are located in Guangdong, Beijing and Shanghai Guangdong Province, Shanghai city and Beijing city are the top provinces in the distribution of in vitro diagnostic reagent manufacturers in drug administration Guangdong Province, Sichuan Province and Gansu Province are the top provinces in the distribution of Chinese Herbal Pieces production enterprises The top provinces of medical gas production enterprises are Jiangsu Province, Shandong Province and Guangdong Province The top provinces of pharmaceutical excipients production enterprises are Jiangsu Province, Shandong Province and Zhejiang Province Henan Province, Shanxi Province and Jiangsu Province are the top provinces in the distribution of special drug manufacturers At the same time, some enterprises are not only engaged in the production of APIs, but also involved in the field of preparations to expand their product coverage Therefore, it can also be classified according to the characteristics of the same type of drugs produced by enterprises (all of the following are replaced by letters): there are 524 chemical APIs (HA), 607 chemical pharmaceutical preparations (HB), 365 chemical pharmaceutical APIs and preparations (HAB), 1 Chemical pharmaceutical preparation and related extracts (HBE), and Chinese patent medicine and other preparations (ZA) d There are 33 manufacturers of proprietary Chinese medicine (ZB), 6 producers of proprietary Chinese medicine and extract (ZE), 44 producers of proprietary Chinese medicine and other APIs (Zab), 3 producers of proprietary Chinese medicine and extract, and 3 producers of APIs (zabe), 1 producer of proprietary Chinese medicine, other APIs and corresponding preparations (ZAE), and 5 producers of proprietary Chinese medicine, extract and corresponding preparations (zbe), There are 37 manufacturers of biological product reagents (sb), 3 producers of in vitro diagnostic reagents (TB), 2 producers of special drug substance (CA), 2 producers of chemical drugs and Chinese patent medicine (Hz), etc Summary: From the statistical data, we can find that after decades of development, chemical medicine, Chinese patent medicine and Chinese herbal pieces have become the main force in the field of medicine in China With the reduction of research and production costs in related fields and the gradual maturity of technology, many pharmaceutical enterprises in China will gradually expand their product lines from their original relatively single product structure, and more into the technical content In the higher biomedical field, the competition among enterprises will be intensified At the same time, it is accompanied by the way of upgrading the biomedical industry from the primary level to the deep level Data source: drug intelligence network database of Chinese drug manufacturers note: the intellectual property rights of the above articles belong to drug intelligence network If you need to reprint, please indicate the source and the link of this article.